Anti-HLA Class II DRB1/HLA-DRB1 Antibody Picoband® (Dylight488 Conjugate)

CAT:
519-A00568-Dylight488
Size:
100 μg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Anti-HLA Class II DRB1/HLA-DRB1 Antibody Picoband® (Dylight488 Conjugate) - image 1

Anti-HLA Class II DRB1/HLA-DRB1 Antibody Picoband® (Dylight488 Conjugate)

  • Background:

    HLA class II histocompatibility antigen, DRB1 beta chain is a protein that in humans is encoded by the HLA-DRB1 gene. This gene is mapped to 6p21.32. DRB1 encodes the most prevalent beta subunit of HLA-DR. Several alleles of DRB1 (shared epitope alleles) are associated with an increased incidence of rheumatoid arthritis. HLA-DRB1 belongs to the HLA class II beta chain paralogs. The class II molecule is a heterodimer consisting of an alpha (DRA) and a beta chain (DRB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The beta chain is approximately 26-28 kDa. It is encoded by 6 exons. It plays a central role in the immune system by presenting peptides derived from extracellular proteins to T helper cells.
  • Description:

    Boster Bio Anti-HLA Class II DRB1/HLA-DRB1 Antibody Picoband® catalog # A00568. Tested in WB applications. This antibody reacts with Human. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.
  • Synonyms:

    HLA class II histocompatibility antigen, DRB1-7 beta chain; MHC class II antigen DRB1*7; DR-7; DR7; HLA-DRB1
  • Gene Name:

    major histocompatibility complex, class II, DR beta 1
  • UniProt:

    P13761
  • Host:

    Rabbit
  • Reactivity:

    Human
  • Cross Reactivity:

    No cross-reactivity with other proteins.
  • Immunogen:

    A synthetic peptide corresponding to a sequence at the N-terminus of human HLA Class II DRB1/HLA-DRB1.
  • Clonality:

    Polyclonal
  • Applications:

    WB
  • Concentration:

    Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.
  • Form:

    Lyophilized
  • Reconstitution:

    Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
  • Function:

    Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route; where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules; and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments; exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides; autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs; other cells of the gastrointestinal tract; such as epithelial cells; express MHC class II molecules and CD74 and act as APCs; which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen; three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs; CD74 undergoes a sequential degradation by various proteases; including CTSS and CTSL; leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells; the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal microenvironment has been implicated in the regulation of antigen loading into MHC II molecules; increased acidification produces increased proteolysis and efficient peptide loading.
  • Storage Conditions:

    Store at -20℃ for one year from date of receipt. After reconstitution, at 4℃ for one month. It can also be aliquotted and stored frozen at -20℃ for six months. Avoid repeated freeze-thaw cycles.
  • Fragment:

    Rabbit IgG
  • Applications Notes:

    Western blot, 0.1-0.5μg/ml
  • Subcellular Location:

    Cell membrane. Single-pass type I membrane protein. Endoplasmic reticulum membrane. Lysosome membrane. Endosome membrane. Late endosome membrane. Trans-Golgi network membrane